- Report: Specialty pharmacy to account for half of all prescription revenue by 2018
- ROUNDTABLE: Pharmacy’s future in sync with technology
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Senate passes Drug Quality and Security Act
- Study from NCPA sheds new light on med synchronization programs
NEW YORK — Express Scripts is readying for a pharmacy network without Walgreens, according to an analyst report published Thursday.
Credit Suisse analyst Edward Kelly reported that Express Scripts issued a letter to clients on Monday encouraging those clients to begin pushing prescriptions to alternative pharmacies. "While this is the next logical step in this very public negotiation, it supports our view that a near-term resolution is unlikely and suggests that the possibility of no deal (while still low) is increasing," Kelly wrote.
The crux of the issue may come down to regulatory approval of the Express Scripts/Medco merger. If approved, that provides Express Scripts significantly more scale, enough so that any migration of prescriptions out of Walgreens' pharmacies could have a material impact, Kelly noted. "For now, Walgreens remains steadfast on its terms, but we believe the company will eventually be forced to make concessions as the loss of [Express Scripts] (before even considering Medco) could pressure Walgreens’ earnings by 20%."